SCHEMBL3782384

SCHEMBL3782384

Fc1cc(F)cc(/C(=C/c2ccccc2Cl)CCl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
TRPA1 O75762 1/20 0.40
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.35
F2R P25116 1/20 0.34
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
HSP90AA1 P07900 1/20 0.32
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32
GRIN3A Q8TCU5 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3782388 1.00 MAPT (0.40) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL2293804 0.88 NPC1 (0.50) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL2293797 0.88 NPC1 (0.50) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL3661458 0.86 TRPA1 (0.39) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL3776016 0.86 TRPA1 (0.39) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL28557804 0.86 MAPT (0.48) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL5050582 0.86 MAPT (0.48) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL29966795 0.86 MAPT (0.48) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL5050581 0.86 MAPT (0.48) MAPTNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL3661208 0.83 MEN1 (0.35) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 MAPT 3389/4885NPC1 4668/4885RAB9A 4287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.